NCT00677365 - Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients | Biotech Hunter

Enrollment

151

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Cystic Fibrosis (CF)

Interventions

DRUG

MP-376

3 dose regimens of MP-376 administered twice daily (BID) or once daily (QD) for 28 days

DRUG

Placebo

same frequency as study drug using the same nebulizer

Trial Locations (50)

10595

Valhalla

12208

Albany

15213

Pittsburgh

19102

Philadelphia

29203

Columbia

29425

Charleston

32801

Orlando

33136

Miami

36608

Mobile

38105

Memphis

40202

Louisville

43205

Columbus

45224

Cincinnati

45404

Dayton

48109

Ann Arbor

49007

Kalamazoo

52242

Iowa City

60025

Chicago

60068

Park Ridge

60453

Oak Lawn

72202

Little Rock

73104

Oklahoma CF Center, Oklahoma City

73112

Oklahoma City

75708

Tyler

78212

San Antonio

84132

Salt Lake City

85016

Phoenix

85724

Tucson

89107

Las Vegas

90027

Childrens Hospital, Los Angeles

90033

Los Angeles

92103

San Diego

92868

Orange

94304

Palo Alto

94611

Oakland

95817

Sacramento

02115

Boston

Unknown

Minneapolis

Berlin

Essen

Frankfurt

Gerlingen

Gieben

Kiel

München

Tübingen

Amsterdam

Groesbeek

Rotterdam

07962

Morristown